Abstract

Vaccine adjuvants are substances associated with antigens that are fundamental to the formation of an intense, durable, and fast immune response. In this context, the use of vaccine adjuvants to generate an effective cellular immune response is crucial for the design and development of vaccines against visceral leishmaniasis. The objective of this study was to evaluate innate inflammatory response induced by the vaccine adjuvants saponin (SAP), incomplete Freund’s adjuvant (IFA), and monophosphoryl lipid A (MPL). After a single dose of adjuvant was injected into the skin of mice, we analyzed inflammatory reaction, selective cell migration, and cytokine production at the injection site, and inflammatory cell influx in the peripheral blood. We found that all vaccine adjuvants were able to promote cell recruitment to the site without tissue damage. In addition, they induced selective migration of neutrophils, macrophages, and lymphocytes. The influx of neutrophils was notable at 12 h in all groups, but at other time points it was most evident after inoculation with SAP. With regard to cytokines, the SAP led to production of interleukin (IL)-2, IL-6, and IL-4. IFA promoted production of tumor necrosis factor (TNF)-α, interferon (IFN)-γ, IL-6, IL-17, IL-4, and IL-10. We also observed that MPL induced high production of IL-2, TNF-α, and IFN-γ, in addition to IL-6, IL-17, and IL-10. In peripheral blood, values of certain cell populations in the local response changed after stimulation. Our data demonstrate that the three vaccine adjuvants stimulate the early events of innate immune response at the injection site, suggesting their ability to increase the immunogenicity of co-administered antigens. Moreover, this work provides relevant information about elements of innate and acquired immune response induced by vaccine adjuvants administered alone.

Highlights

  • The main goal of vaccination is the development of a potent memory response by T cells against specific pathogens, an event that seems to occur in the first week after immunization or infection [1]

  • We evaluated the kinetics of cell migration induced by the vaccine adjuvants SAP, incomplete Freund’s adjuvant (IFA), and monophosphoryl lipid A (MPL) to the site of the injection at 1, 12, 24, 48, 96, 168, and 336 h after sensitization

  • At 48 and 96 h after sensitization, there was an increase in cell migration in SAP (246.160.5657; 212.7631.90), IFA (223.6620.75; 210.6629.29), and MPL (253.96108.3; 272.3625.81) groups as compared to controls

Read more

Summary

Introduction

The main goal of vaccination is the development of a potent memory response by T cells against specific pathogens, an event that seems to occur in the first week after immunization or infection [1]. The research on efficient vaccination focuses on the delivery method and administration route, and on the composition and safety of vaccines [2,3]. In this context, vaccine adjuvants are very important additives. Many adjuvants were found empirically, and progress to understand their mechanism of action has been slow, which partly explains why the number of adjuvants approved for human use is still low [6]. Colloidal aluminum salts (alum) were the only approved adjuvants, but more recently squalene emulsions (MF59) and monophosphoryl lipid A (MPL) have been licensed for usage in Europe [7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call